ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,481.95
0.16%
Dow Jones
38,790.01
0.03%
US Dollar vs MXN
18.4736
-0.34%
Brent Oil
84.435
0.64%
Bitcoin
64,721.15
-2.65%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Korro Bio Inc (KRRO)

  7. Korro Bio Inc (KRRO) Noticias

KRRO

Korro Bio (KRRO)

Korro Bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:KRRO
FechaHoraFuenteTítuloSímboloCompañía
17/06/202415:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
12/06/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
12/06/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
30/05/202415:01GlobeNewswire Inc.Korro to Participate in Upcoming June Investor and Scientific ConferencesNASDAQ:KRROKorro Bio Inc
22/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KRROKorro Bio Inc
20/05/202413:30GlobeNewswire Inc.Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International ConferenceNASDAQ:KRROKorro Bio Inc
14/05/202419:22Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
14/05/202415:34Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:KRROKorro Bio Inc
14/05/202415:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRROKorro Bio Inc
14/05/202415:01GlobeNewswire Inc.Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical OfficerNASDAQ:KRROKorro Bio Inc
18/04/202407:30GlobeNewswire Inc.Korro Announces $70 Million Private PlacementNASDAQ:KRROKorro Bio Inc
01/04/202415:01GlobeNewswire Inc.Korro to Participate in Upcoming Investor ConferencesNASDAQ:KRROKorro Bio Inc
26/03/202415:01GlobeNewswire Inc.Korro Reports Full Year 2023 Financial Results and Highlights Recent ProgressNASDAQ:KRROKorro Bio Inc
27/02/202407:00GlobeNewswire Inc.Korro to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRROKorro Bio Inc
18/01/202407:00GlobeNewswire Inc.Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing PortfolioNASDAQ:KRROKorro Bio Inc
04/01/202407:00GlobeNewswire Inc.Korro to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KRROKorro Bio Inc
20/12/202315:44Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:KRROKorro Bio Inc
07/12/202307:00GlobeNewswire Inc.Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:KRROKorro Bio Inc
28/11/202307:00GlobeNewswire Inc.Korro Bio Appoints Dr. Rachel Meyers to Board of DirectorsNASDAQ:KRROKorro Bio Inc
22/11/202315:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KRROKorro Bio Inc
17/11/202315:23Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:KRROKorro Bio Inc
17/11/202311:38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:KRROKorro Bio Inc
 Showing the most relevant articles for your search:NASDAQ:KRRO

Su Consulta Reciente

NYSE
JPM
JP Morgan Chase
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
NYSE
AXP
American Express
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
NYSE
KO
Coca Cola
CCOM
US30
US 30
NYSE
MCD
McDonalds
USOTC
BNPQY
BNP Paribas (QX)
NYSE
XOM
Exxon Mobil
COIN
SOLUSD
Solana
USI
USTECH100
US Tech 100
CCOM
OILBRENT
Brent Oil
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados